Candida Antibody Panel

This panel detects three types of antibodies (IgA, IgG, and IgM) against Candida albicans, a yeast that normally lives on skin and in the digestive tract. Different antibody types indicate different stages of infection: IgM suggests recent or acute infection, IgG suggests past or chronic exposure, and IgA suggests mucosal exposure. Elevated levels may indicate candida overgrowth, yeast infections, or systemic candidiasis, particularly in immunocompromised individuals.

This test detects IgG antibodies against Candida albicans, a common yeast organism. IgG antibodies indicate past or chronic exposure to Candida, not acute infection. Elevated levels may suggest chronic candidiasis, intestinal overgrowth, or systemic yeast infection, though interpretation is complex and controversial. In healthy people, IgG presence is normal due to environmental exposure. This test is sometimes ordered for suspected chronic yeast infections or immune dysfunction. However, a positive IgG result alone does not diagnose disease—clinical symptoms and additional testing are essential for diagnosis.

This test measures IgA antibodies against Candida albicans, a common fungus that normally inhabits your body. Elevated IgA levels suggest an immune response to Candida overgrowth or mucosal infection. IgA antibodies are particularly important at mucosal surfaces (mouth, gut, respiratory tract). Positive results may indicate oral thrush, vaginal yeast infections, or intestinal Candida overgrowth, helping identify fungal infections that require treatment.

This test measures IgM antibodies against Candida albicans, which are produced early in response to fungal infection. IgM antibodies indicate recent or acute infection, making this test useful for distinguishing new Candida infections from chronic or past exposures. Elevated IgM levels suggest your body is actively fighting a Candida infection, helping determine if antifungal treatment is needed and monitoring treatment response.